Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-10 · accession 0001628280-25-011984 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-11 | 2025-03-10 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | F - Tax | $32.06 | -2,017 | 12.7K | -14% | -$64.7K |
| DM | 2025-03-11 | 2025-03-10 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | M - OptEx | $0.00 | +3,800 | 13.6K | +39% | $0 |
| DM | 2025-03-11 | 2025-03-10 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | M - OptEx | $0.00 | -3,800 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | F | D | 1,062 | $32.06 | 11,836 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 2 | Common | Common Stock | 2025-03-10 | F | D | 955 | $32.06 | 12,681 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 3 | Common | Common Stock | 2025-03-10 | M | A | 2,000 | $0.00 | 12,898 | D | — | — | (F1) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023. |
| 4 | Common | Common Stock | 2025-03-10 | M | A | 1,800 | $0.00 | 13,636 | D | — | — | (F3) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. |
| 5 | Derivative | Performance Share Unit | 2025-03-10 | M | D | 2,000 | $0.00 | 0 | D | $0.00 · — to — | 2,000 Common Stock | (F4) On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. |
| 6 | Derivative | Performance Share Unit | 2025-03-10 | M | D | 1,800 | $0.00 | 0 | D | $0.00 · — to — | 1,800 Common Stock | (F5) On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |